MedPath

The effect of salt intensity on ad libitum intake of tomato soup in different meal settings.

Completed
Conditions
obesitas
overweight
Registration Number
NL-OMON33375
Lead Sponsor
Wageningen Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Healthy (as jugded by the participant)
Age: 18-35 year
Non-smoking
BMI between 18.5 and 25 kg/m2.

Exclusion Criteria

People who score of <5 at a 9-point pleasantness scale for creamy tomato soup
Diabetics
People suffering from kidney diseases
People who followed a diet during the last two months
People who have a restraint eating behaviour
People with swallowing problems

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome is the difference between ad libitum intake of low intense<br /><br>salt soup and ad libitum intake of high intense salt soup. This will be<br /><br>separately determined in the pre-load and mixed lunch setting.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1) The difference between eating rate of the intense salt soup versus high<br /><br>intense salt soup. This will be separately determined in the pre-load and mixed<br /><br>lunch setting.<br /><br>2) The difference in ad libitum intake of low intense salt soup, ideal intense<br /><br>salt soup and high intense salt soup between the pre-load versus the mixed<br /><br>lunch setting (thus intake of low intense salt soup in the pre-load setting is<br /><br>compared with low intense salt soup in the mixed lunch setting, ect)<br /><br>3) The difference in ad libitum intake and eating rate of ideal intense salt<br /><br>soup compared with both low intense salt soup and high intense salt soup.<br /><br>4) The difference in consumption of sweet and savoury sandwich fillings after<br /><br>ad libitum intake of low intense salt soup versus high intense salt soup in the<br /><br>mixed lunch setting. </p><br>
© Copyright 2025. All Rights Reserved by MedPath